Vet InVitro ApS: Financial statements 2023
CVR: 39806797
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Vet InVitro ApS (CVR 39806797) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 271,371 and a net result of DKK -33,204 compared with DKK -71 the year before. That is a decrease of 7.4% compared with the year before. Equity in the 2023 report amounted to DKK -397,627.
- Gross Profit
- DKK 271,371
- Profit/Loss
- DKK -33,204
- Equity
- DKK -397,627
- Total Assets
- DKK 1,141,077
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 271 t. | -33 t. | -398 t. | 0 |
| 2022 | - | 293 t. | -71 | -364 t. | 0 |
| 2021 | - | -255 | -258 t. | -364 t. | - |
| 2020 | - | 384 t. | 133 t. | -142 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Vet InVitro ApS has published its annual report for 2022. Gross profit came to DKK 292,994, and the net result was DKK -71.
About Vet InVitro ApS
Vet InVitro ApS is a Danish company of the type Anpartsselskab based in Rødekro, founded in 2018. The company is registered under the industry Dyrlægeaktiviteter. The company was previously named Vet InVitro IVS. The management consists of Andreas Carstensen and Emma Kathrine Lorenzen. The company is owned by EAC Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 305,986 and a net result of DKK 112,521 compared with DKK -311,350 the year before. Equity in the 2025 report amounted to DKK -596,456.